Stryker Corporation (SYK)

US — Healthcare Sector
Peers: BSX  ABT  MDT  DXCM  EW    ZBH  ZIMV  STE  SNN 

Automate Your Wheel Strategy on SYK

With Tiblio's Option Bot, you can configure your own wheel strategy including SYK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol SYK
  • Rev/Share 60.8279
  • Book/Share 120.5292
  • PB 3.1723
  • Debt/Equity 0.3126
  • CurrentRatio 1.6423
  • ROIC 0.0599

 

  • MktCap 146120787750.0
  • FreeCF/Share 9.3712
  • PFCF 40.8501
  • PE 51.0469
  • Debt/Assets 0.3126
  • DivYield 0.0086
  • ROE 0.1073

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Resumed SYK Citigroup -- Buy -- $450 Feb. 26, 2025
Initiation SYK Wolfe Research -- Outperform -- $405 Sept. 10, 2024

News

PBH vs. SYK: Which Stock Is the Better Value Option?
PBH, SYK
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?

Read More
image for news PBH vs. SYK: Which Stock Is the Better Value Option?
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System
SYK
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Neutral

Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.

Read More
image for news SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
SYK
Published: May 19, 2025 by: PRNewsWire
Sentiment: Neutral

Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich.

Read More
image for news Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker
LMT, ROK, SYK
Published: May 05, 2025 by: CNBC Television
Sentiment: Neutral

The Investment Committee kick off the week with their top picks. Don't miss it!

Read More
image for news Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker
SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View
SYK
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Negative

SYK's first-quarter results reflect strong segmental performance, along with a rise in operating margin.

Read More
image for news SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
BAX, BDX, CAH, DXCM, SYK
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive

This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.

Read More
image for news MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
Strong Segmental Performance to Drive Stryker's Q1 Earnings?
SYK
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Negative

SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.

Read More
image for news Strong Segmental Performance to Drive Stryker's Q1 Earnings?
PBH vs. SYK: Which Stock Is the Better Value Option?
PBH, SYK
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

Read More
image for news PBH vs. SYK: Which Stock Is the Better Value Option?
Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)
SYK
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Neutral

Stryker Corporation (NYSE:SYK ) Citi's 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ET Company Participants Preston Wells - CFO Jason Beach - VP, Finance, IR Conference Call Participants Joanne Wuensch - Citigroup Joanne Wuensch Joanne Wuensch, the medical technology analyst here at Citi Bank. So for our next session, I'm quite thrilled to have the incoming CFO, Preston Wells and Jason Beach, which I think people know quite well.

Read More
image for news Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)
PAHC or SYK: Which Is the Better Value Stock Right Now?
PAHC, SYK
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

Read More
image for news PAHC or SYK: Which Is the Better Value Stock Right Now?
SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?
SYK
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Stryker is gaining momentum with strong Q4 results, innovative medtech solutions and high-growth market expansion. But, is the stock still a buy?

Read More
image for news SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?
Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day
SYK
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headquarters, New York, New York.

Read More
image for news Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day

About Stryker Corporation (SYK)

  • IPO Date 1980-03-17
  • Website https://www.stryker.com
  • Industry Medical - Devices
  • CEO Mr. Kevin A. Lobo
  • Employees 53000

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.